Every publication below is separated by evidence type, research scope, and interpretation limits, with a direct link to the original record.
Educational bibliography only. Publications do not validate products sold by Subversion RX and are not dosing guidance, instructions for use, or medical advice. Laboratory materials are not for human or veterinary use.
Study 01
Human phase 2New England Journal of Medicine · 2023
What researchers examined
A randomized phase 2 trial examining a GIP, GLP-1, and glucagon receptor agonist in adults.
How to interpret it
Phase 2 studies are generally exploratory or dose-finding. They help characterize signals and adverse events but do not by themselves establish broad safety or effectiveness.
Study 02
Human phase 2The Lancet · 2023
What researchers examined
A randomized phase 2 trial examining glycaemic measures, body weight, dose response, and adverse events.
How to interpret it
Phase 2 studies are generally exploratory or dose-finding. They help characterize signals and adverse events but do not by themselves establish broad safety or effectiveness.